| Literature DB >> 34350324 |
Moon Fai Chan1, Rola Al Balushi2, Maryam Al Falahi2, Sangeetha Mahadevan2, Muna Al Saadoon3, Samir Al-Adawi2.
Abstract
BACKGROUND: The Gulf Cooperation Council (GCC), with a predominant 'youth bulge' among its 54 million people, has witnessed an exponential increase in research pertinent to child and adolescent mental health (CAMH). Aside from a few narrative reviews, to date, no critical appraisal examining the magnitude of CAMH has emerged from this region. AIMS: This study aimed to report the prevalence rates of CAMH disorders in the GCC through a systematic review of the existing literature followed by a meta-analysis.Entities:
Keywords: ADHD; Anxiety; Child and adolescent mental health disorders; Depression; Eating disorders; GCC; Metaanalysis; Stress; Systematic review; Tobacco use disorder
Year: 2021 PMID: 34350324 PMCID: PMC8319685 DOI: 10.1016/j.ijpam.2021.04.002
Source DB: PubMed Journal: Int J Pediatr Adolesc Med ISSN: 2352-6467
Fig. 1The PRISMA flow diagram describing the systematic review process.
Fig. 2Prevalence estimates of attention deficit hyperactivity (ADHD) assessed by the Vanderbilt ADHD Diagnostic Scale.
Fig. 3Prevalence estimates of attention deficit hyperactivity (ADHD) assessed using clinical judgment.
Fig. 4Prevalence estimates of attention deficit hyperactivity (ADHD) assessed by the Attention Deficit Disorders Evaluation Scale.
Fig. 5Prevalence estimates of attention deficit hyperactivity (ADHD) assessed by the Strengths and Difficulties Questionnaire.
Fig. 6Prevalence estimates of depression assessed by the Patient Health Questionnaire-9 (PHQ-9).
Fig. 7Prevalence estimates of depression, anxiety, and stress assessed by the DASS.
Fig. 8Prevalence estimates of depression and anxiety assessed by the Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid).
Fig. 9Prevalence estimates of disordered eating (DE) assessed by the Eating Attitudes Test (EAT-26).
Fig. 10Prevalence estimates of smoking assessed by the Global Youth Tobacco Survey.
Characteristics of studies included in Systematic Review [[30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40],45,55,56,[64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74],[77], [78], [79], [80]].
| No. | Author (year) | Country | Sample size (N) | Age range (years) | Study setting | Screening tool | Disorder screened | Positive cases (%) |
|---|---|---|---|---|---|---|---|---|
| 1 | Salem et al. (2014) [ | Kuwait | 135 | 6–15 | Hospital | VADHDDRS-PRS (Arabic)/SSPI/WIS/MINI-KID | ADHD | ADHD = 70 (51.9%) |
| 2 | Bener et al. (2011) [ | Qatar | 1703 | 6–18 | School | Clinical Impression | Phobias | Overall Phobias = 335 (19.7%) |
| 3 | Bradshaw & Kamal (2017) [ | Qatar | 4489 | 6–19 | School | SNAP-IV RS | ADHD | ADHD = 373 (8.3%) |
| 4 | Alshaban et al. (2019) [ | Qatar | 8676 | 5–12 | Schools and medical centers | SCQ/QSS-PTI/ADI-R/ADOS-2 | ASD | ASD = 1398 (0.79%) |
| 5 | Al-Gelban, Al-Amri, & Mostafa (2009) [ | Saudi Arabia | 545 | 14–19 | School | SCL 90-R (Arabic) | Mental health symptoms | Depression = 76 (13.9%); Anxiety = 78 (14.3%) |
| 6 | Al-Haidar (2003) [ | Saudi Arabia | 416 | 0–18 | Hospital | DSM III-R/DSM IV | ADHD | ADHD = 106 (25.5%) |
| 7 | Al Hamed, Taha, Sabra & Bella al. (2008) [ | Saudi Arabia | 1287 | 6–13 | School | ADDES | ADHD | ADHD = 572 (45.11) |
| 8 | Al Gelban (2007) [ | Saudi Arabia | 1723 | 15–19 | School | DASS | Depression, anxiety and stress | Depression = 659 (38.2%) Anxiety = 843 (48.9%) |
| 9 | Al-Gelban, Al-Amri, & Mostafa (2009) [ | Saudi Arabia | 545 | 14–20 | School | DASS | Depression, anxiety and stress | Depression = 226 (41.5%) Anxiety = 361 (66.2%) Stress = 286 (52.5%) |
| 10 | Al-Modayfer & Alatiq (2017) [ | Saudi Arabia | 226 | 0–17 | Community | SDQ/MINI-KID | Psychiatric disorders | ADHD = 38 (17.0%) Any affective (depression) or anxiety disorder = 49 (21.7%) |
| 11 | Al-Qahtani and Al-Harbi (2017) [ | Saudi Arabia | 347 | 17–19 | School | Taif Hospital Scales Series: Anxiety scale | Anxiety | Anxiety = 223 (64.3%) |
| 12 | Al-Sughayr and Ferwana (2012) [ | Saudi Arabia | 354 | 17–20 | School | GHQ-28 | Psychiatric morbidity | Psychiatric morbidity = 170 (48%) |
| 13 | Alatiq, Alshalan, and Almodayfer (2010) [ | Saudi Arabia | 692 | Mean = 16.9 | School | SDQ/MINI-KID | Psychiatric disorders | ADHD = 66 (9.5%); Generalized Anxiety Disorder = 94 (13.64%) |
| 14 | Albuhairan et al. (2017) [ | Saudi Arabia | 9073 | Mean = 15.8 | School | Global school-based student health survey | Bullying, physical violence (PV), anxiety, and sadness | PV = 3021 (33.3%) |
| 15 | Alenazi, Hammad & Mohamed (2019) [ | Saudi Arabia | 375 | 16–19 | School | DASS-42 | Depression/anxiety/stress | Depression = 211 (56.3%) |
| 16 | Alharbi et al. (2019) [ | Saudi Arabia | 1245 | 13–19 | School | PHQ-9/GAD-7 | Depression/anxiety | Depression = 734 (73.5%) |
| 17 | Allihaibi (2015) [ | Saudi Arabia | 172 | 15–19 | School | EAT-26 | Disordered eating attitudes | DEA = 45 (26.2%) |
| 18 | Almuhlafi, Jamilah, Almutairi & Salam (2018) [ | Saudi Arabia | 399 | Mean = 16.8 SD = 0.9 | School | EAT-26 | Disordered eating | Binge eating = 123 (30.8%) Purging = 28 (7.0%) Laxative usage = 21 (5.3%) |
| 19 | Almuneef (2019) [ | Saudi Arabia | 10,156 | Mean = 34.3 | Community | ACEIQ | Child sexual abuse (CSA) | Lifetime CSA (contact form) = 2112 (20.8%); |
| 20 | Alqahtani (2012) [ | Saudi Arabia | 708 | 7–9 | School | VADHDDRS | ADHD | ADHD = 29 (4.1%) |
| 21 | Alqahtani (2010) [ | Saudi Arabia | 642 | 7–9 | School | DSM-IV-TR | ADHD | ADHD = 33 (5.0%) [DSM-IV-TR] |
| 22 | Alzaben et al. (2018) [ | Saudi Arabia | 929 | 6–12 | School | VADHDDRS | ADHD | ADHD = 46 (11.6%) |
| 23 | Amin, Amr & Zaza (2011) [ | Saudi Arabia | 1652 | 15–19 | School | GYTS/FT/PHQ-9/NCS | Tobacco use disorder | Smoking = 358 (21.7%) Cigarettes only = 165 (46.1%), Shisha = (WP or Maasel) = 134 (37.4%) |
| 24 | Elarousy, & Al-Jadaani (2013) [ | Saudi Arabia | 60 | 12–18 | Community | Specially designed, self-administered questionnaire | Emotional abuse | Rejecting = 54 (90.0%) Ignoring = 37 (61.7%) Terrorizing = 37 (61.7%) |
| 25 | Fatima & Ahmad (2018) [ | Saudi Arabia | 314 | 15–19 | School | EAT-26 | Disordered Eating | Disordered Eating = 80 (25.4%) |
| 26 | Gaffar, Alsanosy & Mahfouz (2013) [ | Saudi Arabia | 3923 | 12–21 | School | GYTSQ | Tobacco Use Disorder | Smoking = 679 (17.3%) |
| 27 | Homidi, Obaidat & Hamaidi (2018) [ | Saudi Arabia | 2770 | 6–12 | School | ADHDS | ADHD | ADHD = 321 (11.6%) |
| 28 | Jenahi, Khalil, & Bella (2013) [ | Saudi Arabia | 1009 | 6–15 | School | ADDES | ADHD | ADHD = 107 (11.3%) |
| 29 | Raheel (2015) [ | Saudi Arabia | 1028 | 15–19 | School | BDI | Depression | Depression = 308 (30.0%) |
| 30 | Al-Yateem et al. (2020) [ | UAE | 968 | 13–18 | School | SCARED | Anxiety | Anxiety = 271 (28.0%) |
| 31 | Khamis (2011) [ | UAE | 200 | 11–14 | School | DSM-IV | ADHD | ADHD = 25 (12.5%) |
| 32 | Al-Ghannami et al. (2018) [ | Oman | 328 | 9–10 | School | VADHDDRS-TAS | ADHD | ADHD = 28 (8.8%) |
| 33 | Afifi (2006) [ | Oman | 500 | Mean = 16.99 | School | CDIS | Depression | Depression = 91 (18.3%) |
ADHD = Attention deficit hyperactivity disorder; VADHDDRS=Vanderbilt ADHD diagnostic rating scale; TDR = Tool developed by the researchers; SNAP – IV RS = The Swanson, Nolan and Pelham Teacher and Parent Rating Scale; SCQ=Social Communication Questionnaire; QSS-PTI = Qatar School Survey Patient Telephone Interview; ASD = Autism Spectrum Disorders; ADI-R = Autism Diagnostic Interview-Revised; ADOS-2 = Autism Diagnostic Observation Schedule, Second Edition; SCL 90-R = Symptom-revised Checklist 90; DSM – III R = Diagnostic Statistical Manual, Third Edition, Revised; DSM – IV = Diagnostic Statistical Manual, Fourth Edition; ADDES = Attention Deficit Disorders Evaluation Scale; DASS = Depression, Anxiety and Stress Scale; SDQ=Strengths and difficulties Questionnaire; MINI-KID=The Mini-International Neuropsychiatric Interview for Children and Adolescents; GHQ-28 = General Health Questionnaire; PHQ-9 = Patient Health Questionnaire-9; GAD-7 = General Anxiety Disorder-7; EAT-26 = Eating Attitude Test-26; ACEIQ = Adverse Childhood Experience International Questionnaire; ODD = Occupational Defiant Disorder; CD = Conduct Disorder; GYTS = Global Youth Tobacco Survey; ADHDS = Attention Deficit Hyperactivity Disorder Scale; ADHD IA = ADHD/inattentive type; ADHD HI = ADHD/hyperactivity type; ADHD C = ADHD/combined type; BDI=Beck depression inventory; SCARED=Screen for Child Anxiety Related Disorders Scale; VADHDDRS-PRS=Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS); CDIS=Children's Depression Inventory scale; FT=Fagerstrom Test (nicotine dependence); NCS=National comorbidity survey; DEA = Disordered eating attitudes; VADHDDRS-TAS, National Initiative for Children's Health Quality Vanderbilt Assessment Scales-Teacher Assessment Scale; WIS=Wechsler Intelligence Scale for Children II; SSPI=Semi-structured psychiatric interview.
Evaluation of the qualifying papers using the JBI guidelines [17,33,45,55,56,[64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]].
| No. | Criteria | Q | Q | Q | Q | Q | Q | Q | Q |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Salem et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 2 | Al-Haidar [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes |
| 3 | Al Hamed, Taha, Sabra & Bella [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes |
| 4 | Al Gelban [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 5 | Al-Gelban, Al-Amri, & Mostafa [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 6 | Al-Ghannami et al. [ | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes |
| 7 | Khamis [ | Unclear | Yes | Yes | Yes | Yes | Yes | Unclear | Yes |
| 8 | Almuhlafi, Jamilah, Almutairi & Salam [ | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes |
| 9 | Fatima & Ahmad [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 10 | Gaffar, Alsanosy, & Mahfouz [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 11 | Homidi, Obaidat & Hamaidi [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes |
| 12 | Jenahi, Khalil, and Bella [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 13 | Al Qahtani [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 14 | AlZaben et al. [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 15 | Al Qahtani [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 16 | Alatiq, Alshalan, and Almodayfer [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 17 | Almodayfer and Alatiq [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 18 | AlHarbi et al. [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes |
| 19 | Amin, Amr & Zaza [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 20 | Allihaibi [ | No | Yes | Yes | Yes | Yes | No | Yes | Yes |
| 21 | Alenazi, Hammad, and Mohamed [ | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
Were The Criteria For Inclusion In The Sample Clearly Defined?.
Were The Study Subjects And The Setting Described In Detail?.
Was The Exposure Measured In A Valid And Reliable Way?.
Were Objective, Standard Criteria Used For Measurement Of The Condition?.
Were Confounding Factors Identified?.
Were Strategies To Deal With Confounding Factors Stated?.
Were The Outcomes Measured In A Valid And Reliable Way?.
Was Appropriate Statistical Analysis Used?.